Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) Debt Ratio (2023 - 2026)

Updated

Apimeds Pharmaceuticals US's Debt Ratio was 0.07 in Q2 2026.

Analysis

Apimeds Pharmaceuticals US (APUS) Debt Ratio (2023 - 2026) Analysis & Trends

For FY2025, Debt Ratio at Apimeds Pharmaceuticals US came in at 0.04, down 99.8% from FY2024.

  • In earlier years, Debt Ratio was 19.15 in FY2024 and 0.63 in FY2023.
  • The Q2 2026 figure marks the highest quarterly Debt Ratio since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn - 0.11
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.11
Dec 31, 2025 0.04
Mar 31, 2025 2.40
Dec 31, 2024 19.15
Dec 31, 2023 0.63
API Access

Apimeds Pharmaceuticals US Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=APUS&period=max&api_key=YOUR_API_KEY